Garcia-Manero G - Search Results

1

Preclinical antileukemia activity of JNJ-26481585, a potent second-generation histone deacetylase inhibitor.

Tong WG, Wei Y, Stevenson W, Kuang SQ, Fang Z, Zhang M, Arts J, Garcia-Manero G. Tong WG, et al. Leuk Res. 2010 Feb;34(2):221-8. doi: 10.1016/j.leukres.2009.07.024. Epub 2009 Aug 13. Leuk Res. 2010. PMID: 19682743

2

Expression profile of 11 proteins and their prognostic significance in patients with chronic lymphocytic leukemia (CLL).

Faderl S, Keating MJ, Do KA, Liang SY, Kantarjian HM, O'Brien S, Garcia-Manero G, Manshouri T, Albitar M. Faderl S, et al. Leukemia. 2002 Jun;16(6):1045-52. doi: 10.1038/sj.leu.2402540. Leukemia. 2002. PMID: 12040436

3

Mitoxantrone and prolonged infusion gemcitabine as salvage therapy in patients with acute myelogenous leukemia.

Apostolidou E, Estey E, Cortes J, Garcia-Manero G, Faderl S, Thomas D, Tsimberidou A, Kantarjian H, Giles FJ. Apostolidou E, et al. Leuk Res. 2003 Apr;27(4):301-4. doi: 10.1016/s0145-2126(02)00171-6. Leuk Res. 2003. PMID: 12531220 Clinical Trial.

4

Empirical examination of the neutrophil criterion (>1500 microl(-1)) currently needed to declare CR in AML.

Estey E, Giles F, Cortes J, Beran M, Verstovsek S, Garcia-Manero G, Faderl S, Kantarjian H. Estey E, et al. Leuk Res. 2003 Jun;27(6):475-9. doi: 10.1016/s0145-2126(03)00031-6. Leuk Res. 2003. PMID: 12648505

5

Prognostic implications of epigenetic silencing of p15INK4B in acute promyelocytic leukemia.

Garcia-Manero G. Garcia-Manero G. Leukemia. 2003 May;17(5):839-40. doi: 10.1038/sj.leu.2402908. Leukemia. 2003. PMID: 12750694 No abstract available.

6

Outcome in patients with nonleukemic granulocytic sarcoma treated with chemotherapy with or without radiotherapy.

Tsimberidou AM, Kantarjian HM, Estey E, Cortes JE, Verstovsek S, Faderl S, Thomas DA, Garcia-Manero G, Ferrajoli A, Manning JT, Keating MJ, Albitar M, O'Brien S, Giles FJ. Tsimberidou AM, et al. Leukemia. 2003 Jun;17(6):1100-3. doi: 10.1038/sj.leu.2402958. Leukemia. 2003. PMID: 12764375

7

Gemtuzumab ozogamicin, fludarabine, cytarabine and cyclosporine combination regimen in patients with CD33+ primary resistant or relapsed acute myeloid leukemia.

Tsimberidou A, Cortes J, Thomas D, Garcia-Manero G, Verstovsek S, Faderl S, Albitar M, Kantarjian H, Estey E, Giles FJ. Tsimberidou A, et al. Leuk Res. 2003 Oct;27(10):893-7. doi: 10.1016/s0145-2126(03)00022-5. Leuk Res. 2003. PMID: 12860008 Clinical Trial.

8

Phase I and pharmacodynamic study of Triapine, a novel ribonucleotide reductase inhibitor, in patients with advanced leukemia.

Giles FJ, Fracasso PM, Kantarjian HM, Cortes JE, Brown RA, Verstovsek S, Alvarado Y, Thomas DA, Faderl S, Garcia-Manero G, Wright LP, Samson T, Cahill A, Lambert P, Plunkett W, Sznol M, DiPersio JF, Gandhi V. Giles FJ, et al. Leuk Res. 2003 Dec;27(12):1077-83. doi: 10.1016/s0145-2126(03)00118-8. Leuk Res. 2003. PMID: 12921943 Clinical Trial.

9

Methylation, aging, and pediatric acute lymphocytic leukemia.

Garcia-Manero G. Garcia-Manero G. Leukemia. 2003 Nov;17(11):2063-4. doi: 10.1038/sj.leu.2403117. Leukemia. 2003. PMID: 12931218 No abstract available.

10

DNA methylation in haematological malignancies: the role of decitabine.

Hennessy BT, Garcia-Manero G, Kantarjian HM, Giles FJ. Hennessy BT, et al. Expert Opin Investig Drugs. 2003 Dec;12(12):1985-93. doi: 10.1517/13543784.12.12.1985. Expert Opin Investig Drugs. 2003. PMID: 14640942 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,008 results

Search Page

Filters